Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 9 studies | 22% ± 4% | |
| lung | 7 studies | 21% ± 6% | |
| brain | 6 studies | 29% ± 8% | |
| eye | 4 studies | 26% ± 6% | |
| liver | 4 studies | 28% ± 10% | |
| bone marrow | 3 studies | 18% ± 2% | |
| uterus | 3 studies | 28% ± 6% | |
| intestine | 3 studies | 22% ± 5% | |
| lymph node | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1536.23 | 1443 / 1445 | 100% | 40.41 | 183 / 183 |
| lung | 99% | 1702.52 | 575 / 578 | 100% | 36.45 | 1150 / 1155 |
| intestine | 100% | 1784.09 | 966 / 966 | 99% | 35.11 | 521 / 527 |
| stomach | 100% | 1374.53 | 359 / 359 | 99% | 35.00 | 282 / 286 |
| breast | 100% | 1952.65 | 459 / 459 | 98% | 40.56 | 1093 / 1118 |
| brain | 99% | 1010.87 | 2611 / 2642 | 99% | 31.80 | 697 / 705 |
| ovary | 100% | 2112.57 | 180 / 180 | 97% | 24.41 | 419 / 430 |
| pancreas | 99% | 1029.16 | 325 / 328 | 98% | 24.04 | 174 / 178 |
| bladder | 100% | 1710.62 | 21 / 21 | 95% | 28.55 | 478 / 504 |
| prostate | 100% | 1318.08 | 245 / 245 | 95% | 27.36 | 476 / 502 |
| uterus | 100% | 1797.86 | 170 / 170 | 94% | 30.25 | 433 / 459 |
| thymus | 100% | 1544.57 | 653 / 653 | 94% | 24.42 | 567 / 605 |
| skin | 100% | 1970.15 | 1809 / 1809 | 91% | 35.87 | 431 / 472 |
| kidney | 100% | 1093.38 | 89 / 89 | 88% | 25.13 | 795 / 901 |
| adrenal gland | 100% | 2306.15 | 258 / 258 | 86% | 21.60 | 197 / 230 |
| liver | 96% | 768.75 | 216 / 226 | 82% | 14.32 | 332 / 406 |
| adipose | 100% | 2092.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1671.39 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2697.12 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1412.84 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 29.62 | 43 / 45 |
| heart | 93% | 940.28 | 799 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 86% | 25.70 | 25 / 29 |
| peripheral blood | 70% | 1125.37 | 649 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 69% | 16.49 | 55 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0016602 | Cellular component | CCAAT-binding factor complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | CEBPZ |
| Protein name | CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor) CCAAT enhancer binding protein zeta |
| Synonyms | CBF2 |
| Description | FUNCTION: Stimulates transcription from the HSP70 promoter. |
| Accessions | Q03701 ENST00000446769.1 C9J9W7 ENST00000234170.10 |